Marco Investment Management’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$2.08M Buy
34,278
+8,325
+32% +$485K 0.16% 95
2025
Q4
$1.4M Sell
25,953
-2,500
-9% -$120K 0.11% 103
2025
Q3
$1.28M Sell
28,453
-998
-3% -$46.6K 0.1% 108
2025
Q2
$1.36M Sell
29,451
-1,287
-4% -$63.2K 0.11% 103
2025
Q1
$1.87M Sell
30,738
-3,400
-10% -$198K 0.17% 91
2024
Q4
$1.93M Buy
34,138
+500
+1% +$27.9K 0.17% 88
2024
Q3
$1.74M Sell
33,638
-3,250
-9% -$152K 0.15% 93
2024
Q2
$1.53M Buy
36,888
+50
+0.1% +$2.24K 0.14% 99
2024
Q1
$2M Buy
36,838
+1,381
+4% +$70.3K 0.19% 87
2023
Q4
$1.82M Sell
35,457
-3,966
-10% -$208K 0.19% 89
2023
Q3
$2.29M Sell
39,423
-6,568
-14% -$402K 0.26% 77
2023
Q2
$2.94M Sell
45,991
-918
-2% -$61.6K 0.32% 73
2023
Q1
$3.25M Buy
46,909
+533
+1% +$37.6K 0.37% 66
2022
Q4
$3.34M Sell
46,376
-1,942
-4% -$146K 0.39% 64
2022
Q3
$3.44M Sell
48,318
-24
-0% -$1.74K 0.44% 62
2022
Q2
$3.72M Buy
48,342
+1,205
+3% +$91.8K 0.43% 61
2022
Q1
$3.44M Buy
47,137
+100
+0.2% +$6.71K 0.35% 74
2021
Q4
$2.93M Sell
47,037
-1,370
-3% -$80.4K 0.29% 81
2021
Q3
$2.86M Buy
48,407
+1,610
+3% +$106K 0.32% 83
2021
Q2
$3.13M Buy
46,797
+4,580
+11% +$299K 0.36% 67
2021
Q1
$2.67M Buy
42,217
+598
+1% +$37.2K 0.35% 72
2020
Q4
$2.58M Buy
41,619
+1,852
+5% +$114K 0.37% 65
2020
Q3
$2.4M Buy
39,767
+7,400
+23% +$445K 0.39% 61
2020
Q2
$1.9M Buy
32,367
+3,914
+14% +$234K 0.35% 64
2020
Q1
$1.59M Sell
28,453
-630
-2% -$38.5K 0.34% 64
2019
Q4
$1.87M Buy
29,083
+227
+0.8% +$13K 0.29% 75
2019
Q3
$1.46M Sell
28,856
-1,020
-3% -$47.9K 0.25% 81
2019
Q2
$1.35M Buy
29,876
+5,588
+23% +$260K 0.24% 84
2019
Q1
$1.16M Sell
24,288
-5,228
-18% -$260K 0.22% 90
2018
Q4
$1.53M Sell
29,516
-608
-2% -$32.7K 0.3% 77
2018
Q3
$1.87M Sell
30,124
-5,296
-15% -$314K 0.27% 82
2018
Q2
$1.96M Buy
35,420
+6,095
+21% +$329K 0.3% 77
2018
Q1
$1.85M Sell
29,325
-300
-1% -$19.3K 0.29% 80
2017
Q4
$1.81M Buy
29,625
+1,500
+5% +$93.8K 0.28% 83
2017
Q3
$1.79M Sell
28,125
-3,837
-12% -$224K 0.28% 84
2017
Q2
$1.78M Sell
31,962
-250
-0.8% -$13.6K 0.29% 80
2017
Q1
$1.75M Sell
32,212
-700
-2% -$38.4K 0.3% 81
2016
Q4
$1.92M Buy
32,912
+9,183
+39% +$502K 0.34% 82
2016
Q3
$1.28M Buy
23,729
+14,400
+154% +$925K 0.23% 95
2016
Q2
$686K Buy
9,329
+500
+6% +$35.3K 0.13% 125
2016
Q1
$564 Hold
8,829
0.08% 128
2015
Q4
$607K Buy
8,829
+4
+0% +$264 0.11% 127
2015
Q3
$522K Buy
8,825
+5
+0.1% +$317 0.1% 131
2015
Q2
$587K Buy
8,820
+1,004
+13% +$66.2K 0.1% 127
2015
Q1
$504K Buy
7,816
+5
+0.1% +$313 0.09% 129
2014
Q4
$461K Buy
7,811
+5
+0.1% +$282 0.06% 138
2014
Q3
$400K Buy
7,806
+905
+13% +$45.2K 0.06% 138
2014
Q2
$335K Buy
6,901
+428
+7% +$21.1K 0.06% 147
2014
Q1
$336K Buy
6,473
+584
+10% +$31.1K 0.07% 145
2013
Q4
$313 Buy
5,889
+5
+0.1% +$255 0.02% 148
2013
Q3
$272K Buy
5,884
+6
+0.1% +$263 0.06% 147
2013
Q2
$263K Buy
+5,878
New +$255K 0.08% 119

Other funds holding BMY

Marco Investment Management's BMY Position: Q1 2026 in Review

Marco Investment Management increased its Bristol-Myers Squibb (BMY) stake by 32% in Q1 2026, buying an estimated $485K and bringing the position to 34,278 shares worth $2.08M. The position accounts for 0.16% of the portfolio, ranked #95.

Marco Investment Management first reported a position in BMY in Q2 2013 and has held it in 52 quarters since. The position peaked at $3.72M in Q2 2022. 2,520 funds tracked by Wall St. Rank hold BMY as of Q1 2026.

  • Marco Investment Management held 34,278 shares of Bristol-Myers Squibb worth $2.08M as of Q1 2026.
  • Marco Investment Management bought 8,325 Bristol-Myers Squibb shares in Q1 2026, an estimated $485K.
  • Bristol-Myers Squibb made up 0.16% of Marco Investment Management's portfolio in Q1 2026, its #95 holding.
  • Marco Investment Management first reported a position in Bristol-Myers Squibb in Q2 2013 and has held it in 52 quarters since.
  • Marco Investment Management's Bristol-Myers Squibb position peaked at $3.72M in Q2 2022.
  • 2,520 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2026.

Based on Marco Investment Management's 13F filing for Q1 2026, filed 8 May 2026.